Journal article icon

Journal article

Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis

Abstract:
Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet light, were not generated in vitro. Signatures of normal and defective DNA repair and replication continued to be generated at roughly stable mutation rates. Signatures of APOBEC cytidine deaminase DNA-editing exhibited substantial fluctuations in mutation rate over time with episodic bursts of mutations. The initiating factors for the bursts are unclear, although retrotransposon mobilization may contribute. The examined cell lines constitute a resource of live experimental models of mutational processes, which potentially retain patterns of activity and regulation operative in primary human cancers.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.cell.2019.02.012

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Human Genetics Wt Centre
Role:
Author
ORCID:
0000-0002-7572-3196


Publisher:
Cell Press
Journal:
Cell More from this journal
Volume:
176
Issue:
6
Pages:
1282-1294
Publication date:
2019-03-07
Acceptance date:
2019-01-27
DOI:
EISSN:
1097-4172
ISSN:
0092-8674
Pmid:
30849372


Language:
English
Keywords:
Pubs id:
pubs:982824
UUID:
uuid:3eaa87d5-6c57-4896-b643-4db448745563
Local pid:
pubs:982824
Source identifiers:
982824
Deposit date:
2019-04-05
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP